Companion animal veterinarians treat pets and generally work in private clinics and hospitals. They most often care for cats and dogs, but also treat other pets, such as birds, ferrets, and rabbits. Specific medications commonly used today that are derived from animal venoms, toxins, or secretions include captopril, eptifibatide (Integrilin), lepirudin, and exenatide (Byetta).
Introduction of new products for companion animals with advanced veterinary drugs owing to increased spending on R&D will spur the market growth. The increased demand for Companion Animal Drugs including parasiticides in order to protect pet animals from fleas, parasites, ticks and even mosquitoes will fuel the market expansion. Rising obesities in animals is another factor playing a crucial role in the companion animal drugs market demand.
Growing obesity rates in companion animals, rising preference for ordering medicines from online pharmacies, and growing pet adoption in households are among the leading factors augmenting the market growth. Increasing consumer awareness regarding animal health and favorable government policies promoting the acceptance of veterinary care products are also supporting the market expansion. Rising prevalence of diseases in pets requires proper treatment of animals, thereby recording surge in companion animal drugs.
Read More@ https://bit.ly/3BBOLV9
